Study shows anti-clotting drug reduced bleeding events in patients with atrial fibrillation

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to

SGLT2 inhibitor empagliflozin is shown to be safe and effective for treating patients who have suffered a heart attack

Credit: Pixabay/CC0 Public Domain The SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are hospitalized for acute myocardial infarction (MI),

First randomized trial shows education for health care professionals can improve guideline implementation

Credit: CC0 Public Domain Adherence to atrial fibrillation (AF) guideline recommendations was found to be poor in clinical practice across Europe, but a structured educational program for health care professionals